ResMed Inc. (RMD) said Wednesday that effective March 1, Michael Farrell will succeed Dr. Peter Farrell as the company's chief executive officer and be appointed to its board of directors.
Robert Douglas will become ResMed's president and chief operating officer.
Current CEO, chairman of the board and founder, Dr. Farrell, will become executive chairman.
Together, Mr. Farrell and Mr. Douglas will comprise the office of the CEO and Dr. Farrell will work together with them on an as-needed basis through the end of calendar year 2013, when he will transition to non-executive chairman.
In addition, Dr. Jim Hollingshead has been named president, Americas.
Michael Farrell joined ResMed in 2000 and became president, Americas in 2011, responsible for Americas sales and commercial operations. Previously, Mick was senior vice president, sleep strategic business unit from 2007 to 2011. Mick is the son of Dr. Peter Farrell.
Douglas joined ResMed in 2001 as vice president of corporate marketing and has since excelled in additional ResMed roles including president - Asia Pacific and chief, global supply operations, responsible for global manufacturing and commercial distribution and sales operations in the Asia Pacific region; COO - Asia Pacific; and COO - Sydney.
For comments and feedback: editorial@rttnews.com